As of July 2025 MacroGenics has a market cap of HK$0.78 Billion. This makes MacroGenics the world's 9278th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | HK$0.78 B | -50.29% |
2024 | HK$1.57 B | -66.23% |
2023 | HK$4.66 B | 44.6% |
2022 | HK$3.22 B | -57.99% |
2021 | HK$7.67 B | -23.02% |
2020 | HK$9.96 B |
On Jul 29th, 2025 the market cap of MacroGenics was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() Xencor XNCR | HK$4.92 B | 529.72% | ๐บ๐ธ USA |
![]() Pfizer PFE | HK$1.084 T | 138,494.26% | ๐บ๐ธ USA |
![]() Merck MRK | HK$1.628 T | 208,046.89% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | HK$1.115 T | 142,446.45% | ๐บ๐ธ USA |
![]() Amgen AMGN | HK$1.281 T | 163,645.62% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | HK$5.376 T | 687,008.01% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | HK$748.53 B | 95,567.42% | ๐บ๐ธ USA |